<乌鸦传媒>Neoadjuvant Dual ICI Leads to Clinical Benefit in Operable NSCLC More than one-third of patients achieved major pathologic response with nivolumab-ipilimumab. Feb 18, 2021
<乌鸦传媒>New Drug OK'd for Chemo-Induced Myelosuppression in SCLC CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
<乌鸦传媒>Dustin Diamond's Small Cell Lung Cancer "Saved by the Bell" actor diagnosed after exhaustive testing Feb 02, 2021
<乌鸦传媒>KRAS Inhibitor Continues to Impress in NSCLC Sotorasib yielded deep and durable responses in over one-third of patients Feb 01, 2021
<乌鸦传媒>Nab-Paclitaxel as Possible Option for Relapsed NSCLC Noninferior to docetaxel for OS, though impact on clinical practice questioned Feb 01, 2021
<乌鸦传媒>Should COVID-Strained Centers Hit Pause on Lung Cancer Screening? A debate on what stopping scans would do to health systems, patients Feb 01, 2021
<乌鸦传媒>Promising Data for Preop Checkpoint Inhibition in NSCLC Major response rate of 21%, encouraging survival with single-agent atezolizumab Jan 31, 2021
<乌鸦传媒>First-Ever Survival Bump in Relapsed Mesothelioma OS, PFS improved with nivolumab, but questions remain about alternatives, biomarkers Jan 30, 2021
<乌鸦传媒>Dual Checkpoint Blockade No Help in PD-L1-High NSCLC Single-agent pembrolizumab wins out as first-line therapy for advanced disease Jan 30, 2021
<乌鸦传媒>COVID Affects Cancer Care, Patients' Mental Health Studies: fewer diagnoses, more severe disease, worse outcomes, distressed patients Jan 29, 2021
<乌鸦传媒>Montana Oncologist Fired for Misdiagnosing, Overtreating Patients But some rally around him Jan 26, 2021
<乌鸦传媒>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo News, features, and commentary about cancer-related issues Jan 21, 2021
<乌鸦传媒>Targeted Combo Fails in EGFR-Mutant NSCLC Osimertinib-bevacizumab no better than osimertinib alone Jan 07, 2021
<乌鸦传媒>Baby Boys Get Cancer From Mom During Birth Report highlights potential fetal implications of undiagnosed maternal cervical cancer Jan 06, 2021
<乌鸦传媒>Lorlatinib Shows 'Striking' CNS Activity in ALK Lung Cancer But unusual adverse events may hold therapy back Nov 18, 2020
<乌鸦传媒>CDK4/6 Inhibitor in SCLC Cuts Chemo-Induced Myelosuppression Reduced severe neutropenia and less need for supportive care with trilaciclib Oct 20, 2020
<乌鸦传媒>Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status Oct 17, 2020
<乌鸦传媒>Drug Active in 'Undruggable' KRAS-Mutant NSCLC Responses in a third of patients, disease control rate approaching 90% Sep 20, 2020
<乌鸦传媒>A Closer Look at FDA Decision to Pull Lorcaserin More cancers, multiple primaries, and deaths in CAMELLIA-TIMI 61 influenced agency decision Sep 09, 2020
<乌鸦传媒>Even 'Light' Smoking Ups Lung Cancer Risk Mortality approaches that of heavy smokers Sep 09, 2020
<乌鸦传媒>In Lupus, Older Age and Male Sex Raise Cancer Risk Role of most medications, though, not yet clear Aug 21, 2020
<乌鸦传媒>Chemo-Free Regimen Boosts OS in Mesothelioma Big advantage for nivolumab-ipilimumab in nonepithelioid tumors drives advantage over chemo Aug 09, 2020
<乌鸦传媒>Another ALK Drug Tops Crizotinib in First-Line NSCLC Ensartinib doubled PFS over older standard, with improved CNS activity Aug 08, 2020
<乌鸦传媒>COVID-19 More Deadly Than Cancer Itself? Highlights from the AACR conference on COVID-19 and cancer Jul 24, 2020
<乌鸦传媒>The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<乌鸦传媒>Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<乌鸦传媒>Paradigm Shift Coming for Early NSCLC? Postoperative osimertinib doubles DFS in patients with stages Ib-IIIa EGFR+ lung cancer May 28, 2020
<乌鸦传媒>End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News' News, features, and commentary about cancer-related issues May 28, 2020
<乌鸦传媒>6-Week Keytruda Safe, Effective in Melanoma Schedule gets FDA approval for all adult indications Apr 30, 2020
<乌鸦传媒>COVID-19 Mortality Spikes in Patients With Lung, Blood Cancers Those with metastatic disease also at special risk for poor outcomes Apr 28, 2020
<乌鸦传媒>How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really? Real-world data offer word of caution for oncologists Apr 01, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>No DNA Damage Seen With Single Low-Dose CT Scan Some reassurance for annual lung cancer screening safety Mar 10, 2020
<乌鸦传媒>Rush Limbaugh's Advanced Lung Cancer Conservative talk show host announces diagnosis Feb 13, 2020
<乌鸦传媒>PD-1 vs PD-L1 Inhibitors: Do Outcomes Differ? Meta-analysis suggests they aren't equivalent Dec 27, 2019
<乌鸦传媒>Pembrolizumab Shows Survival Benefit in KRAS-Mutant NSCLC Improved OS, PFS, and response rates compared to chemo in first-line Dec 16, 2019
<乌鸦传媒>AHA Dedicates $20 Million to Youth Vaping Research Association and partners aim to "hold e-cigarette companies publicly accountable for their lies" Nov 16, 2019
<乌鸦传媒>Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
<乌鸦传媒>Abnormal Shadow on Chest Radiograph Culture findings were key in making the diagnosis Nov 11, 2019
